Companies / Amerigo Scientific / GLD1-Glucose Dehydrogenase
Amerigo Scientific

GLD1-Glucose Dehydrogenase | Amerigo Scientific

BBI Solutions offers a next generation FAD-dependent GlucoseDehydrogenase (FAD-GDH). FAD-GDH with reduced xylose interference is part of our market leading range of enzymes for blood glucose monitoring, it reduces cross reactivity with a range of sugars, provides increased specificity to glucose and improves reactivity and stability.

Our two grades of FAD-GDH (GLD1 and GLD3), offer proven performance in a range of systems, the decision on which one’s right for you will depend on your individual platform.

Reviews


No reviews yet

ABOUT THE COMPANY

Amerigo Scientific is a distribution company focused on providing critical products and services to the biomedical and life science research communities. Although a new company, Amerigo Scientific's founder has had more than 20 years of rich experience in the biomedical and biochemical fields, and has established close contacts with key personnel in...
READ MORE